Guy Goodwin is Emeritus Professor of Psychiatry at the University of Oxford, Oxford, UK. He has served as a member of the Wellcome Trust Neurosciences Panel, the Council of the British Association for Psychopharmacology, the Clinical Fellowships Panel and Advisory Board of the Medical Research Council and the Agence Nationale de la Recherche panel of the Institut National de la Santé et de la Recherche Médicale.
Professor Goodwin is a Fellow of the American College of Neuropsychopharmacology and has previously held the position of President of the British Association for Psychopharmacology (2004–2005). He is Past President of the European College of Neuropsychopharmacology and Emeritus Senior Investigator on the faculty of the UK’s National Institute for Health Research. He is a Thomson Reuters highly cited researcher (top 1% in the field).
His research interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorders, with a focus on developing new treatments. He has been a lead investigator in clinical trials for mood disorders, including the BALANCE and CEQUEL studies. His current interest is in the potential to improve treatment using new technology.
EM-53628 - Date of preparation: February 2021